Personalis, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Personalis, Inc. (PSNL) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $466.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-02-26
- Personalis, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $466.00K, a 47.17% decline from fiscal 2024.
- Personalis, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $882.00K, a 32.10% decline from fiscal 2023.
- Personalis, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $1.30M, a 10.65% increase from fiscal 2022.
- Personalis, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $1.17M, a 27.89% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $466.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $882.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $1.30M 10-K · filed 2025-02-27 |
| 2022-12-31 | $1.17M 10-K · filed 2024-02-28 |
| 2021-12-31 | $918.00K 10-K · filed 2023-02-23 |
| 2020-12-31 | $567.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $389.00K 10-K · filed 2021-02-25 |
| 2018-12-31 | $275.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |